erbium has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fidecicchi, T; Gambacciani, M; Gaspar, A | 1 |
| Arêas, F; Conde, DM; Costa-Paiva, L; Valadares, ALR | 1 |
| Banu, N; Camacho-Villegas, TA; Cialla-May, D; de la Rosa, E; Panikar, SS; Patrón-Soberano, OA; Ramírez-García, G; Vallejo-Cardona, AA | 1 |
1 trial(s) available for erbium and Breast Neoplasms
| Article | Year |
|---|---|
Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors.
Topics: Breast Neoplasms; Cancer Survivors; Dyspareunia; Erbium; Female; Humans; Lasers, Solid-State; Pilot Projects; Prospective Studies; Treatment Outcome; Vaginal Diseases | 2023 |
2 other study(ies) available for erbium and Breast Neoplasms
| Article | Year |
|---|---|
The effect of vaginal erbium laser treatment on sexual function and vaginal health in women with a history of breast cancer and symptoms of the genitourinary syndrome of menopause: a prospective study.
Topics: Breast Neoplasms; Erbium; Female; Humans; Lasers, Solid-State; Menopause; Middle Aged; Prospective Studies; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Treatment Outcome; Vaginal Diseases | 2019 |
Novel anti-HER2 peptide-conjugated theranostic nanoliposomes combining NaYF
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Erbium; Female; Fluorides; Humans; Infrared Rays; Liposomes; Magnetite Nanoparticles; Methylene Blue; Microscopy, Confocal; Nanostructures; Peptide Library; Peptides; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Receptor, ErbB-2; Yttrium | 2019 |